🇺🇸 FDA
Patent

US 10894063

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

granted A61KA61K2039/5154A61K2039/5156

Quick answer

US patent 10894063 (Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy) held by Iovance Biotherapeutics, Inc. expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Iovance Biotherapeutics, Inc.
Grant date
Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61K, A61K2039/5154, A61K2039/5156, A61K2039/5158, A61K2039/55533